Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy|Continue
JAMA Oncology
Sign In
Individual Sign In
Sign inCreate an Account
Access through your institution
Sign In
This Issue
Editorial
July 20, 2023
Cathy J.Bradley,PhD, MPA1; K. RobinYabroff,PhD2; Ya-Chen TinaShih,PhD3,4
Author Affiliations Article Information
-
1University of Colorado Comprehensive Cancer Center and Colorado School of Public Health, Aurora
-
2Surveillance and Health Equity Science Department, American Cancer Society, Atlanta, Georgia
-
3Section of Cancer Economics and Policy, Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston
-
4University of California–Los Angeles Jonsson Comprehensive Cancer Center and UCLA School of Medicine, Los Angeles
JAMA Oncol. 2023;9(9):1202-1204. doi:10.1001/jamaoncol.2023.2226
- Original Investigation Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer Drugs
MichaelLam,PharmD; TimothéeOlivier,MD; AlysonHaslam,PhD; JordanTuia,BA; VinayPrasad,MD, MPH
JAMA Oncology
Full Text
Oral targeted agents for cancer are among the most expensive outpatient prescription drugs dispensed in the US.1 These drugs, often distributed as specialty drugs, can cost more than $170 000 per patient per year.2 Patients in the US pay a greater share of their health care costs than patients living in other developed countries. As a result, terms such as “financial burden,” “financial hardship,” and “financial toxicity” have risen, especially in the US, to describe the untenable phenomenon patients, particularly those treated for cancer, face: treatment can result in long-term financial hardship3 that may be so severe as to result in medical bankruptcy4,5 or inability to complete recommended treatment protocols.6 Moreover, the cost of targeted oral medications for cancer treatment continues to rise. One study7 using Surveillance, Epidemiology, and End Results (SEER)-Medicare data reported that oral prescription drugs for leukemia increased by 27% between 2007 and 2013, reaching $2.35 billion. Another study8 analyzing the SEER-Medicare 5% Cancer File showed that mean 30-day total spending on targeted oral anticancer drugs more than doubled in 5 years, from $4011 in 2011 to $8857 in 2016.
Full Text
Add or change institution
Comment
Read More About
Targeted and Immune Therapy Oncology Pharmacoeconomics Pharmacoepidemiology
Citation
Bradley CJ, Yabroff KR, Shih YT. Discarded Targeted Oral Anticancer Medication—A Hard Pill to Swallow? JAMA Oncol. 2023;9(9):1202–1204. doi:10.1001/jamaoncol.2023.2226
Manage citations:
Ris (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley
© 2024
Comment
Add or change institution
Artificial Intelligence ResourceCenter
Others Also Liked
Select Your Interests
Customize your JAMA Network experience by selecting one or more topics from the list below.
- Academic Medicine
- Acid Base, Electrolytes, Fluids
- Allergy and Clinical Immunology
- American Indian or Alaska Natives
- Anesthesiology
- Anticoagulation
- Art and Images in Psychiatry
- Artificial Intelligence
- Assisted Reproduction
- Bleeding and Transfusion
- Cardiology
- Caring for the Critically Ill Patient
- Challenges in Clinical Electrocardiography
- Climate and Health
- Climate Change
- Clinical Challenge
- Clinical Decision Support
- Clinical Implications of Basic Neuroscience
- Clinical Pharmacy and Pharmacology
- Complementary and Alternative Medicine
- Consensus Statements
- Coronavirus (COVID-19)
- Critical Care Medicine
- Cultural Competency
- Dental Medicine
- Dermatology
- Diabetes and Endocrinology
- Diagnostic Test Interpretation
- Drug Development
- Electronic Health Records
- Emergency Medicine
- End of Life, Hospice, Palliative Care
- Environmental Health
- Equity, Diversity, and Inclusion
- Ethics
- Facial Plastic Surgery
- Gastroenterology and Hepatology
- Genetics and Genomics
- Genomics and Precision Health
- Geriatrics
- Global Health
- Guide to Statistics and Methods
- Guidelines
- Hair Disorders
- Health Care Delivery Models
- Health Care Economics, Insurance, Payment
- Health Care Quality
- Health Care Reform
- Health Care Safety
- Health Care Workforce
- Health Disparities
- Health Inequities
- Health Policy
- Health Systems Science
- Hematology
- History of Medicine
- Humanities
- Hypertension
- Images in Neurology
- Implementation Science
- Infectious Diseases
- Innovations in Health Care Delivery
- JAMA Infographic
- Law and Medicine
- Leading Change
- Less is More
- LGBTQIA Medicine
- Lifestyle Behaviors
- Medical Coding
- Medical Devices and Equipment
- Medical Education
- Medical Education and Training
- Medical Journals and Publishing
- Melanoma
- Mobile Health and Telemedicine
- Narrative Medicine
- Nephrology
- Neurology
- Neuroscience and Psychiatry
- Notable Notes
- Nursing
- Nutrition
- Nutrition, Obesity, Exercise
- Obesity
- Obstetrics and Gynecology
- Occupational Health
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Pain Medicine
- Palliative Care
- Pathology and Laboratory Medicine
- Patient Care
- Patient Information
- Pediatrics
- Performance Improvement
- Performance Measures
- Perioperative Care and Consultation
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacogenetics
- Pharmacy and Clinical Pharmacology
- Physical Medicine and Rehabilitation
- Physical Therapy
- Physician Leadership
- Poetry
- Population Health
- Primary Care
- Professional Well-being
- Professionalism
- Psychiatry and Behavioral Health
- Public Health
- Pulmonary Medicine
- Radiology
- Regulatory Agencies
- Reproductive Health
- Research, Methods, Statistics
- Resuscitation
- Rheumatology
- Risk Management
- Scientific Discovery and the Future of Medicine
- Shared Decision Making and Communication
- Sleep Medicine
- Sports Medicine
- Stem Cell Transplantation
- Substance Use and Addiction Medicine
- Surgery
- Surgical Innovation
- Surgical Pearls
- Teachable Moment
- Technology and Finance
- The Art of JAMA
- The Arts and Medicine
- The Rational Clinical Examination
- Tobacco and e-Cigarettes
- Toxicology
- Translational Medicine
- Trauma and Injury
- Treatment Adherence
- Ultrasonography
- Urology
- Users' Guide to the Medical Literature
- Vaccination
- Venous Thromboembolism
- Veterans Health
- Violence
- Women's Health
- Workflow and Process
- Wound Care, Infection, Healing
Save Preferences
Privacy Policy | Terms of Use
X
.
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Rent this article from DeepDyve
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Rent this article from DeepDyve
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Customize your interests
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy